Email updates

Keep up to date with the latest news and content from Critical Care and BioMed Central.

Letter

Circulating fatty acid binding protein as a marker of intestinal failure in septic patients

Marcel Cerqueira César Machado, Hermes Vieira Barbeiro, Fabiano Pinheiro da Silva* and Heraldo Possolo de Souza

Author Affiliations

Sao Paulo University School of Medicine, Laboratory of Clinical Emergencies (LIM/51), Av. Dr. Arnaldo, 455 room 3189, CEP: 01246903, Sao Paulo - SP, Brazil

For all author emails, please log on.

Critical Care 2012, 16:455  doi:10.1186/cc11653


The electronic version of this article is the complete one and can be found online at: http://ccforum.com/content/16/6/455


Published:5 November 2012

© 2012 BioMed Central Ltd

Letter

Intestinal hypoperfusion in sepsis may result in loss of gut barrier and bacterial translocation, further complicating the already severe septic state. Intestinal dysfunction in critically ill patients is underestimated and may be associated with worse prognosis. The absence of a valid marker of intestinal dysfunction in sepsis makes it difficult to include this parameter in a patient's clinical evaluation. We describe intestinal fatty acid-binding protein as a marker of intestinal failure in septic shock.

Plasma citrulline has been used as a marker of intestinal dysfunction because critically ill patients have an acute reduction of enterocyte mass with a reduction in citrulline synthesis. However, the influence of renal failure on plasma citrulline levels must be re-evaluated [1]. Circulating intestinal fatty acid binding protein (I-FABP or FABP6) has been found to be an early marker of intestinal necrosis after aortic surgery [2], after Pringle maneuver in liver surgery [3] and in acute pancreatitis [4]. The aim of this study was to evaluate the value of circulating fatty acid binding protein in the evaluation of intestinal failure in critically ill patients.

Plasma I-FABP concentrations were measured in blood samples from 72 critically ill patients admitted to the University of São Paulo Department of Emergency Medicine and from 10 healthy controls. Patients comprised 28 critically ill non-infected patients, 13 patients with severe sepsis, 24 patients with septic shock and five patients recovering from septic shock (48 hours without vasopressors). The prevalent sources of infection were pulmonary, urinary tract and catheter-related. The project was approved by the hospital ethic committee and the patients signed informed consent.

We observed a significant elevation of serum levels of I-FABP in patients with septic shock when compared with healthy controls (Figure 1).

thumbnailFigure 1. Intestinal fatty acid binding protein plasma levels in critically ill patients and healthy controls.

The intestinal functions are complex and comprise not only nutrient digestion and absorption but also a defensive action as an immunological and physical barrier to the external environment. Damage in this complex architecture may lead to increased intestinal permeability and bacterial translocation. Intestinal dysfunction in critically ill patients is difficult to evaluate and is probably common, despite underestimation. I-FABP is a 15 kDa protein located at the tips of intestinal mucosal villi and is usually undetected in the plasma circulation [5]. Intestinal ischemia even for a short period of time is followed by changes in plasma levels of I-FABP due to intestinal villi damage [4]. We assume that I-FABP may constitute a useful marker for acute intestinal failure in critically ill patients. Future studies in larger cohorts of critically ill patients may confirm these results and validate I-FABP as a marker of intestinal failure, integrating this system into the evaluation and treatment of critically ill septic patients.

Abbreviations

I-FABP: intestinal fatty acid binding protein.

Competing interests

The authors declare that they have no competing interests.

References

  1. Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G: Acute intestinal failure in critically ill patients: is plasma citrulline the right marker?

    Intensive Care Med 2011, 37:911-917. PubMed Abstract | Publisher Full Text OpenURL

  2. Vermeulen Windsant IC, Hellenthal FA, Derikx JP, Prins MH, Buurman WA, Jacobs MJ, Schurink GW: Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study.

    Ann Surg 2012, 255:796-803. PubMed Abstract | Publisher Full Text OpenURL

  3. Dello SA, Reisinger KW, van Dam RM, Bemelmans MH, van Kuppevelt TH, van den Broek MA, Olde Damink SW, Poeze M, Buurman WA, Dejong CH: Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia.

    PLoS One 2012, 7:e30539. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  4. Pan L, Wang X, Li W, Li N, Li J: The intestinal fatty acid binding protein diagnosing gut dysfunction in acute pancreatitis: a pilot study.

    Pancreas 2010, 39:633-638. PubMed Abstract | Publisher Full Text OpenURL

  5. Pelsers MM, Hermens WT, Glatz JF: Fatty acid-binding proteins as plasma markers of tissue injury.

    Clin Chim Acta 2005, 352:15-35. PubMed Abstract | Publisher Full Text OpenURL